Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Cogstate Limited

CGS.AXASX
Healthcare
Medical - Healthcare Information Services
$2.31
$0.00(0.00%)
Australian Market opens in NaNh NaNm

Cogstate Limited Fundamental Analysis

Cogstate Limited (CGS.AX) shows moderate financial fundamentals with a PE ratio of 23.38, profit margin of 19.65%, and ROE of 26.76%. The company generates $0.1B in annual revenue with weak year-over-year growth of -23.33%.

Key Strengths

ROE26.76%
Operating Margin21.39%
Current Ratio3.96

Areas of Concern

PEG Ratio5.22
We analyze CGS.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 41.4/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
41.4/100

We analyze CGS.AX's fundamental strength across five key dimensions:

Efficiency Score

Excellent

CGS.AX demonstrates superior asset utilization.

ROA > 10%
16.43%

Valuation Score

Moderate

CGS.AX shows balanced valuation metrics.

PE < 25
23.38
PEG Ratio < 2
5.22

Growth Score

Moderate

CGS.AX shows steady but slowing expansion.

Revenue Growth > 5%
-23.33%
EPS Growth > 10%
25.42%

Financial Health Score

Excellent

CGS.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
3.96

Profitability Score

Excellent

CGS.AX achieves industry-leading margins.

ROE > 15%
26.76%
Net Margin ≥ 15%
19.65%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CGS.AX Expensive or Cheap?

P/E Ratio

CGS.AX trades at 23.38 times earnings. This indicates a fair valuation.

23.38

PEG Ratio

When adjusting for growth, CGS.AX's PEG of 5.22 indicates potential overvaluation.

5.22

Price to Book

The market values Cogstate Limited at 5.06 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.06

EV/EBITDA

Enterprise value stands at 16.25 times EBITDA. This signals the market has high growth expectations.

16.25

How Well Does CGS.AX Make Money?

Net Profit Margin

For every $100 in sales, Cogstate Limited keeps $19.65 as profit after all expenses.

19.65%

Operating Margin

Core operations generate 21.39 in profit for every $100 in revenue, before interest and taxes.

21.39%

ROE

Management delivers $26.76 in profit for every $100 of shareholder equity.

26.76%

ROA

Cogstate Limited generates $16.43 in profit for every $100 in assets, demonstrating efficient asset deployment.

16.43%

Following the Money - Real Cash Generation

Operating Cash Flow

Cogstate Limited produces operating cash flow of $15.65M, showing steady but balanced cash generation.

$15.65M

Free Cash Flow

Cogstate Limited generates strong free cash flow of $14.89M, providing ample flexibility for dividends, buybacks, or growth.

$14.89M

FCF Per Share

Each share generates $0.09 in free cash annually.

$0.09

FCF Yield

CGS.AX converts 3.78% of its market value into free cash.

3.78%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

23.38

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

5.22

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.06

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.61

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.01

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.96

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.27

vs 25 benchmark

ROA

Return on assets percentage

0.16

vs 25 benchmark

ROCE

Return on capital employed

0.22

vs 25 benchmark

How CGS.AX Stacks Against Its Sector Peers

MetricCGS.AX ValueSector AveragePerformance
P/E Ratio23.3829.73 Better (Cheaper)
ROE26.76%777.00% Weak
Net Margin19.65%-23829.00% (disorted) Strong
Debt/Equity0.010.26 Strong (Low Leverage)
Current Ratio3.964.62 Strong Liquidity
ROA16.43%-17661.00% (disorted) Strong

CGS.AX outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cogstate Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

39.18%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

423.38%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

860.45%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ